+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Automated Cell Processing Systems for Cell Therapy Market - Global Forecast 2026-2032- Product Image
Automated Cell Processing Systems for Cell Therapy Market - Global Forecast 2026-2032- Product Image
Sale

Automated Cell Processing Systems for Cell Therapy Market - Global Forecast 2026-2032

  • Report

  • 182 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6081878
UP TO OFF until Dec 31st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Automated Cell Processing Systems for Cell Therapy Market is projected to reach USD 1.96 Billion in 2026. It is expected to continue growing at a CAGR of 8.77%, reaching USD 3.28 Billion by 2032.

Automated Cell Processing Systems for Cell Therapy: Executive Overview

Automated cell processing systems are becoming central to the development and manufacture of cell therapies by integrating tasks such as cell selection, washing, concentration, activation, culture, formulation, and filling into controlled workflows. Their strategic value lies in improving process consistency, reducing manual interventions, strengthening traceability, and supporting closed or functionally closed operations. Adoption is shaped by clinical-stage requirements, manufacturing readiness, regulatory expectations, facility design, workforce capabilities, and compatibility with diverse cell types and therapy protocols.

Automation Is Reshaping Cell-Therapy Manufacturing Workflows

The landscape is shifting from highly manual, operator-dependent procedures toward standardized, digitally documented, and increasingly modular processing. Developers and manufacturers are prioritizing systems that can support aseptic handling, single-use consumables, electronic batch records, in-process monitoring, and reproducible parameter control. Integration with quality systems and manufacturing execution platforms is becoming more important as organizations seek stronger chain-of-identity and chain-of-custody management. At the same time, equipment flexibility remains essential because autologous, allogeneic, immune-cell, stem-cell, and gene-modified workflows impose different requirements for throughput, contamination control, and process control.

Artificial Intelligence Strengthens Process Control and Decision Support

Artificial intelligence is contributing to cell-processing operations through pattern recognition, anomaly detection, predictive maintenance, image-based assessment, and optimization of process parameters. When linked with sensor data and historical batch records, AI tools can help identify deviations earlier and support more consistent decisions during culture, expansion, and formulation. Their effective use depends on data quality, validated algorithms, explainability, cybersecurity, and clear human oversight. Regulatory acceptance will require documented model performance, change control, and evidence that AI-assisted decisions do not compromise product quality or patient safety.

Regional Dynamics Reflect Different Manufacturing and Regulatory Priorities

North America is characterized by advanced cell-therapy development, established bioprocessing infrastructure, and strong demand for scalable, compliant automation. Europe emphasizes harmonized quality expectations, cross-border manufacturing coordination, and integration with advanced therapy medicinal-product frameworks. Asia-Pacific combines rapid clinical development, expanding manufacturing capacity, and varied regulatory maturity across markets. Latin America is building capability through specialist centers, technology transfer, and partnerships that address infrastructure and workforce constraints. The Middle East is investing in healthcare modernization and localized advanced-therapy capacity, while Africa’s progress is concentrated in leading medical and research hubs, with access, funding, and technical training remaining important considerations.

Economic and Policy Groups Reveal Distinct Adoption Conditions

ASEAN markets are developing cell-therapy capabilities unevenly, making interoperable systems, training, and service support particularly valuable. BRICS economies combine substantial scientific capacity with diverse regulatory, infrastructure, and localization requirements. The European Union benefits from common regulatory structures while retaining national differences in reimbursement, procurement, and facility implementation. G7 countries generally place strong emphasis on validation, data integrity, automation maturity, and resilient supply chains. GCC countries are supporting advanced healthcare infrastructure and centralized specialist services, whereas NATO members show increasing interest in dependable biomedical supply chains, dual-use manufacturing resilience, and cross-border research collaboration.

Country-Level Priorities Span Scale, Regulation, and Technical Readiness

The United States and Canada combine advanced clinical ecosystems with demand for scalable, compliant, and digitally integrated processing. Germany, France, Italy, Spain, and the United Kingdom emphasize rigorous quality systems, specialized manufacturing, and alignment between clinical translation and regulatory requirements. Australia is developing advanced-therapy capability around research institutions and specialist production centers. China, Japan, South Korea, and India are expanding domestic cell-therapy research and manufacturing while addressing localization, validation, and workforce needs. Brazil and Mexico are strengthening regional capacity through academic, hospital, and industrial collaboration. Russia’s development environment is influenced by domestic infrastructure, regulatory evolution, and supply-chain considerations.

Industry Leaders Should Build Flexible, Validated, and Data-Ready Platforms

Leaders should select automation architectures that can accommodate multiple therapy modalities without creating unnecessary complexity in validation or change control. Priority actions include mapping critical quality attributes to automated process parameters, implementing robust chain-of-identity controls, qualifying single-use assemblies, and designing electronic records for auditability. Organizations should also establish staged technology-transfer plans, invest in operator and quality training, and assess serviceability across target regions. AI initiatives should begin with well-defined use cases, governed datasets, independent validation, and human review. Partnerships with clinical centers, contract manufacturers, and technology providers can reduce implementation risk when responsibilities, data ownership, and regulatory accountability are clearly defined.

Methodology Combines Structured Market Review With Application and Geography Analysis

This executive summary uses a structured review of the automated cell-processing systems landscape for cell therapy. The analysis considers workflow functions, therapy modalities, automation architectures, quality and regulatory requirements, digital integration, regional conditions, economic groupings, and country-level adoption factors. Insights are synthesized from publicly verifiable regulatory materials, peer-reviewed research, technical literature, clinical-development information, and documented manufacturing practices. The assessment is qualitative and directional; it intentionally excludes market estimates, market sizing, market shares, forecasts, and unsupported company-specific claims.

Automation Will Be a Core Enabler of Reproducible Cell-Therapy Delivery

Automated cell processing systems are increasingly important to the transition of cell therapy from specialized laboratory procedures toward repeatable, controlled, and scalable manufacturing. The strongest opportunities are associated with platforms that combine process flexibility, closed handling, electronic traceability, validated analytics, and practical integration with existing facilities. Regional and country differences mean that adoption strategies must be tailored to infrastructure, regulation, workforce, and supply-chain conditions. Organizations that align automation with quality-by-design principles and disciplined digital governance will be better positioned to improve consistency while supporting the evolving requirements of clinical and commercial cell-therapy production.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Automated Cell Processing Systems for Cell Therapy Market, by Component Type
7.1. Introduction
7.2. Accessories
7.3. Consumables
7.3.1. Kits & Cartridges
7.3.2. Reagents
7.3.2.1. Culture Media
7.3.2.2. Cytokines
7.3.2.3. Growth Factors
7.4. Instruments
7.4.1. Cell Expansion Systems
7.4.2. Cell Processing Workstations
7.4.3. Cell Selection Systems
7.4.3.1. Flow Cytometry
7.4.3.2. Magnetic Bead
7.4.3.3. Microfluidic
7.4.4. Cell Washing & Concentration Systems
7.5. Services
7.6. Software
8. Automated Cell Processing Systems for Cell Therapy Market, by Cell Type
8.1. Introduction
8.2. Dendritic Cells
8.3. NK Cells
8.4. Stem Cells
8.5. T Cells
9. Automated Cell Processing Systems for Cell Therapy Market, by Workflow Stage
9.1. Introduction
9.2. Cell Expansion
9.3. Cell Selection
9.4. Cryopreservation & Storage
9.5. Formulation & Fill-Finish
9.6. Washing & Concentration
10. Automated Cell Processing Systems for Cell Therapy Market, by Technology
10.1. Introduction
10.2. Closed Systems
10.3. Open Systems
11. Automated Cell Processing Systems for Cell Therapy Market, by Application
11.1. Introduction
11.2. Allogeneic Therapy
11.3. Autologous Therapy
12. Automated Cell Processing Systems for Cell Therapy Market, by End User
12.1. Introduction
12.2. Academic & Research Institutes
12.3. Contract Manufacturing Organizations
12.4. Hospitals & Clinics
12.5. Pharmaceutical & Biotech Companies
13. Automated Cell Processing Systems for Cell Therapy Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Automated Cell Processing Systems for Cell Therapy Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Automated Cell Processing Systems for Cell Therapy Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. BD Biosciences
17.2. BioSpherix, LLC
17.3. Cellares Inc.
17.4. CellGenix GmbH
17.5. Cook Regentec LLC
17.6. Danaher Corporation
17.7. Fresenius Kabi AG
17.8. Lonza Group AG
17.9. Merck KGaA
17.10. Miltenyi Biotec GmbH
17.11. PALL Corporation
17.12. Sartorius AG
17.13. Showa Denko Materials Co., Ltd.
17.14. STEMCELL Technologies Inc.
17.15. Takara Bio Inc.
17.16. Terumo Corporation
17.17. Thermo Fisher Scientific Inc.
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Automated Cell Processing Systems for Cell Therapy Market, Years Considered for the Study
FIGURE 2. Global Automated Cell Processing Systems for Cell Therapy Market, Research Design
FIGURE 3. Global Automated Cell Processing Systems for Cell Therapy Market, Research Framework
FIGURE 4. Global Automated Cell Processing Systems for Cell Therapy Market, Data Triangulation
FIGURE 5. Global Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2025 vs 2032 (%)
FIGURE 7. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2025 vs 2032 (%)
FIGURE 9. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2025 vs 2032 (%)
FIGURE 11. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 13. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2025 vs 2032 (%)
FIGURE 17. Global Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Automated Cell Processing Systems for Cell Therapy Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Automated Cell Processing Systems for Cell Therapy Market Segmentation & Coverage
TABLE 2. Global Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
TABLE 3. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 4. Global Accessories Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Accessories Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Accessories Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Consumables Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Consumables Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Consumables Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Kits & Cartridges Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Kits & Cartridges Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Kits & Cartridges Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Reagents Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Reagents Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Reagents Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Culture Media Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Culture Media Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Culture Media Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Cytokines Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Cytokines Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Cytokines Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Growth Factors Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Growth Factors Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Growth Factors Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Cell Expansion Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Cell Expansion Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Cell Expansion Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Cell Processing Workstations Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Cell Processing Workstations Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Cell Processing Workstations Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Cell Selection Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Cell Selection Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Cell Selection Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Flow Cytometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Flow Cytometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Flow Cytometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Magnetic Bead Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Magnetic Bead Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Magnetic Bead Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Microfluidic Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Microfluidic Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Microfluidic Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Cell Washing & Concentration Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Cell Washing & Concentration Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Cell Washing & Concentration Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Software Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Software Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Software Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 56. Global Dendritic Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 57. Global Dendritic Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 58. Global Dendritic Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 59. Global NK Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global NK Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global NK Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Stem Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Stem Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Stem Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global T Cells Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global T Cells Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global T Cells Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 69. Global Cell Expansion Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Cell Expansion Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Cell Expansion Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Cell Selection Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Cell Selection Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Cell Selection Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Cryopreservation & Storage Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Cryopreservation & Storage Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Cryopreservation & Storage Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Formulation & Fill-Finish Market Size, by Region, 2017-2032 (USD Million)
TABLE 79. Global Formulation & Fill-Finish Market Size, by Group, 2017-2032 (USD Million)
TABLE 80. Global Formulation & Fill-Finish Market Size, by Country, 2017-2032 (USD Million)
TABLE 81. Global Washing & Concentration Market Size, by Region, 2017-2032 (USD Million)
TABLE 82. Global Washing & Concentration Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. Global Washing & Concentration Market Size, by Country, 2017-2032 (USD Million)
TABLE 84. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 85. Global Closed Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Closed Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Closed Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Open Systems Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Open Systems Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Open Systems Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Global Allogeneic Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Allogeneic Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Allogeneic Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Autologous Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Autologous Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Autologous Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 99. Global Academic & Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 100. Global Academic & Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 101. Global Academic & Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 102. Global Contract Manufacturing Organizations Market Size, by Region, 2017-2032 (USD Million)
TABLE 103. Global Contract Manufacturing Organizations Market Size, by Group, 2017-2032 (USD Million)
TABLE 104. Global Contract Manufacturing Organizations Market Size, by Country, 2017-2032 (USD Million)
TABLE 105. Global Hospitals & Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 106. Global Hospitals & Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 107. Global Hospitals & Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 108. Global Pharmaceutical & Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 109. Global Pharmaceutical & Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. Global Pharmaceutical & Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 111. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 113. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 114. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 115. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 116. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 117. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 118. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 119. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 123. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 125. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 126. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 127. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 128. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 129. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 130. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 131. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 132. North America Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 133. North America Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 134. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 135. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 136. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 137. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 138. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 139. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 140. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 141. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 142. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 143. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 144. Latin America Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 145. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 147. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 148. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 149. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 150. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 151. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 152. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 153. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Europe Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 156. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 158. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 159. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 160. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 161. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 162. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 163. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 164. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 165. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. Middle East Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 167. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Region, 2017-2032 (USD Million)
TABLE 168. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 169. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 170. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 171. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 172. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 173. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 174. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 175. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 176. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 177. Africa Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 178. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 179. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 180. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 181. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 182. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 183. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 184. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 185. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 186. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 187. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 188. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 189. ASEAN Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 191. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 192. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 193. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 194. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 195. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 196. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 197. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 198. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 199. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 200. GCC Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 201. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 202. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 203. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 204. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 205. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 206. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 207. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 208. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 209. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 211. European Union Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 212. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 213. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 214. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 215. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 216. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 217. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 218. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 219. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 220. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 221. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 222. BRICS Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 223. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 224. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 225. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 226. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 227. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 228. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 229. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 230. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 231. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 233. G7 Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 234. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Group, 2017-2032 (USD Million)
TABLE 235. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 236. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 237. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 238. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 239. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 240. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 241. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 242. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 243. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. NATO Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 245. Global Automated Cell Processing Systems for Cell Therapy Market Size, by Country, 2017-2032 (USD Million)
TABLE 246. United States Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
TABLE 247. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 248. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 249. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 250. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 251. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 252. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 253. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 254. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 255. United States Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 256. United States Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 257. Canada Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
TABLE 258. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 259. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 260. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 261. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 262. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 263. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 264. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 265. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 266. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 267. Canada Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
TABLE 269. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 270. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 271. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 272. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 273. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 274. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 275. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 276. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 277. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 278. Mexico Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 279. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
TABLE 280. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 281. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 282. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 283. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 284. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 285. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 286. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 287. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 288. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. Brazil Automated Cell Processing Systems for Cell Therapy Market Size, by End User, 2017-2032 (USD Million)
TABLE 290. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, 2017-2032 (USD Million)
TABLE 291. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Component Type, 2017-2032 (USD Million)
TABLE 292. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Consumables, 2017-2032 (USD Million)
TABLE 293. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Reagents, 2017-2032 (USD Million)
TABLE 294. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 295. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Selection Systems, 2017-2032 (USD Million)
TABLE 296. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Cell Type, 2017-2032 (USD Million)
TABLE 297. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Workflow Stage, 2017-2032 (USD Million)
TABLE 298. United Kingdom Automated Cell Processing Systems for Cell Therapy Market Size, by Technology, 2017-2032 (USD Million)
TABLE 299. United Kingdom Automated Cell Processing Syst

Companies Mentioned

  • BD Biosciences
  • BioSpherix, LLC
  • Cellares Inc.
  • CellGenix GmbH
  • Cook Regentec LLC
  • Danaher Corporation
  • Fresenius Kabi AG
  • Lonza Group AG
  • Merck KGaA
  • Miltenyi Biotec GmbH
  • PALL Corporation
  • Sartorius AG
  • Showa Denko Materials Co., Ltd.
  • STEMCELL Technologies Inc.
  • Takara Bio Inc.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.

Related Topics

Related Reports

Automated and Closed Cell Therapy Processing Systems Market Report 2026 - Product Image

Automated and Closed Cell Therapy Processing Systems Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Automated and Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report by Workflow (Separation, Expansion, Apheresis), Type (Stem Cell Therapy), Scale (Commercial Scale), and Region with Growth Forecasts, 2026-2033 - Product Image

Automated and Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report by Workflow (Separation, Expansion, Apheresis), Type (Stem Cell Therapy), Scale (Commercial Scale), and Region with Growth Forecasts, 2026-2033

  • Report
  • 130 Pages
  • Global
From
Automated & Closed Cell Therapy Processing Systems Market - Global Forecast 2026-2032 - Product Image

Automated & Closed Cell Therapy Processing Systems Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Automated Cell Processing System Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Cell Therapy Processing Step, Scale of Operation, End User and Key Geographical Regions - Product Image

Automated Cell Processing System Market: Industry Trends and Global Forecasts, Till 2035 - Distribution by Cell Therapy Processing Step, Scale of Operation, End User and Key Geographical Regions

  • Report
  • 184 Pages
  • Global
From
Cell Therapy Technologies Market by Product, Process, Type, Application - Global Forecast to 2030 - Product Image

Cell Therapy Technologies Market by Product, Process, Type, Application - Global Forecast to 2030

  • Report
  • 432 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.